Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Neurology

Why Are AST and ALT Elevated in Duchenne Muscular Dystrophy?

At a Glance

In Duchenne muscular dystrophy, fragile skeletal muscles can release AST and ALT into the blood, causing results that resemble liver disease. A markedly high creatine kinase level, often with normal bilirubin and GGT, supports muscle breakdown, while symptoms and other tests help assess the liver.

When a child is diagnosed with Duchenne muscular dystrophy (DMD), parents are often confused to hear that a doctor initially suspected a liver problem. The reason for this mix-up is that two specific enzymes—AST (aspartate aminotransferase) and ALT (alanine aminotransferase)—are commonly measured during routine blood work to check liver health. However, these enzymes are not only found in the liver; they are also present in skeletal muscle [1].

In DMD, the lack of the protein dystrophin causes muscle cell membranes to become fragile and break down. This allows the AST and ALT inside the muscle cells to leak into the bloodstream [2]. When a doctor sees high levels of these enzymes on a blood test, they may initially suspect the liver is damaged, when in fact, the enzymes are coming from the muscles.

The “Liver” Misdiagnosis Delay

It is a recognized possibility for families to experience a delay in a DMD diagnosis because of elevated AST and ALT [3]. A doctor might order liver ultrasounds, metabolic tests, or infectious disease panels to find the source of the “liver” problem [4]. In rare instances, children have even undergone liver biopsies before the true cause was discovered [5].

This happens because AST and ALT are standard parts of a comprehensive metabolic panel, which is a routine blood test. Because they are often referred to as “liver enzymes,” muscle-related elevations can sometimes be overlooked initially [1]. In early DMD, both AST and ALT can be severely elevated, sometimes reaching hundreds of units per liter [6].

Creatine Kinase (CK): The Key to the Puzzle

The turning point in the diagnostic journey often happens when a doctor checks a creatine kinase (CK) level. CK is an enzyme that is much more specific to muscle breakdown [7]. While AST and ALT can indicate issues in either the liver or the muscles, a markedly elevated CK level points strongly toward muscle damage [6][8].

In children with Duchenne (and sometimes in symptomatic female carriers [9]), CK levels are typically markedly elevated—often many times above the laboratory’s reference range [6]. Once a markedly high CK is identified, it supports a muscle source for the abnormal results [8][7]. This typically prompts a referral to a neuromuscular specialist and genetic testing to confirm a DMD diagnosis.

In one specific study of male patients referred for unexplained high AST and ALT who also had elevated CK, 47% (85 of 182) were eventually diagnosed with Duchenne or Becker muscular dystrophy [10]. This highlights how helpful a CK test can be when AST and ALT are persistently high without a clear liver explanation.

What Do These Tests Mean?

Test Where it is found What it can tell us
AST & ALT Liver, muscle, and other tissues. Elevated levels suggest cell injury, but cannot prove whether the source is the liver or the muscles on their own.
CK (Creatine Kinase) Primarily in muscle tissue. Markedly elevated levels strongly point to muscle breakdown, but do not diagnose DMD on their own.
Bilirubin & GGT Associated with the liver and bile ducts. Often remain normal if AST/ALT are rising due to muscle breakdown. Helpful for distinguishing the source, but normal levels do not rule out every liver issue.

What This Means for Your Child

If your child had elevated AST and ALT during the diagnostic process for Duchenne, it often reflects the muscle breakdown that is the hallmark of DMD. However, children with DMD can still develop unrelated liver issues, so the care team will look at the overall pattern rather than treating normal liver tests as proof that the liver is perfectly fine.

  • Other Liver Tests: Doctors will often look at bilirubin and GGT (gamma-glutamyl transferase). These are often normal when AST/ALT elevation is caused primarily by skeletal muscle injury [7].
  • Levels Change Over Time: You may notice that AST, ALT, and CK levels decrease as your child gets older. This does not mean the DMD is improving; rather, it happens because there is a gradual loss of muscle mass over time, so there is less muscle tissue breaking down and leaking enzymes [11][12].
  • Monitoring is Individualized: There is no single routine protocol for monitoring CK, AST, or ALT after a DMD diagnosis. Repeat testing depends on the clinical situation, especially if your child starts a new medication that could affect the liver [13].

When to Suspect a True Liver Problem

Because your child’s AST and ALT may run high due to their muscles, it is important to know the physical signs of genuine liver distress. Contact your care team promptly if you notice:

  • Yellowing of the skin or eyes (jaundice)
  • Persistently dark urine or pale stools
  • Significant abdominal swelling or pain
  • Persistent vomiting
  • Unusual bleeding or bruising
  • New confusion or severe fatigue

Knowing how to interpret these early blood tests can help alleviate worries, while keeping you prepared for ongoing medical conversations.

Common questions in this guide

Why can Duchenne muscular dystrophy raise AST and ALT?
Duchenne muscular dystrophy causes a shortage of dystrophin, which makes skeletal muscle cells fragile. When those cells break down, AST and ALT can leak into the blood, even when the liver is not the main source.
Does a high AST or ALT mean my child has liver disease?
No. AST and ALT are found in both the liver and skeletal muscle, so high levels alone cannot identify the source. Doctors may compare creatine kinase (CK), bilirubin, gamma-glutamyl transferase (GGT), symptoms, and other results to determine whether muscle injury or a separate liver problem is more likely.
Which blood test helps show that high AST and ALT are coming from muscle?
A creatine kinase (CK) test is especially useful because CK is found mainly in muscle. A markedly high CK supports muscle breakdown, but CK alone does not diagnose Duchenne muscular dystrophy; genetic testing and clinical evaluation may still be needed.
Can high AST and ALT delay a Duchenne diagnosis?
Yes. Because these results are often called liver enzymes, clinicians may first investigate liver disease with imaging or other tests. If CK is also markedly high or the liver evaluation does not explain the results, referral to a neuromuscular specialist and genetic testing can help identify Duchenne muscular dystrophy.
Why can AST, ALT, and CK fall as Duchenne muscular dystrophy progresses?
These levels may fall as a child loses muscle mass because there is less muscle tissue available to break down and release enzymes. A decrease does not mean Duchenne muscular dystrophy is improving, so the results should be interpreted with the child’s clinical status by the care team.
What symptoms could point to a separate liver problem in a child with DMD?
Contact your child’s care team promptly for yellowing of the skin or eyes, persistently dark urine or pale stools, significant abdominal swelling or pain, persistent vomiting, unusual bleeding or bruising, new confusion, or severe fatigue. These symptoms can have different causes, but they warrant timely medical assessment.
How often should AST, ALT, and CK be checked after a DMD diagnosis?
There is no single testing schedule for every child after a Duchenne muscular dystrophy diagnosis. The care team may repeat these tests based on symptoms, prior results, and medicines or supplements that could affect the liver.

Get notified when new evidence is published on Duchenne muscular dystrophy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Biomarkers of liver diseases.

    Tamber SS, Bansal P, Sharma S, et al.

    Molecular biology reports 2023; (50(9)):7815-7823 doi:10.1007/s11033-023-08666-0.

    PMID: 37482588
  2. 2

    Cathepsin S Contributes to the Pathogenesis of Muscular Dystrophy in Mice.

    Tjondrokoesoemo A, Schips TG, Sargent MA, et al.

    The Journal of biological chemistry 2016; (291(19)):9920-8 doi:10.1074/jbc.M116.719054.

    PMID: 26966179
  3. 3

    Transaminitis in a Three-year-old Boy with Duchenne Muscular Dystrophy.

    Xie Q, Feng Y, Li J, et al.

    Journal of clinical and translational hepatology 2020; (8(4)):474-475 doi:10.14218/JCTH.2020.00038.

    PMID: 33447533
  4. 4

    Duchenne Muscular Dystrophy Presenting as Incidental Hyper-Transaminasasemia in a Two-Month-Old Male.

    Chibuzo UN, Bruman M, Holguin A, Bangaru B

    Cureus 2023; (15(2)):e35498 doi:10.7759/cureus.35498.

    PMID: 37007358
  5. 5

    Severe Combined Immunodeficiency with De Novo Duchenne Muscular Dystrophy Mutation.

    Shah KP, Ramachandran V, Nicholas SK, et al.

    JPGN reports 2022; (3(1)):e135 doi:10.1097/PG9.0000000000000135.

    PMID: 37168752
  6. 6

    Muscular Dystrophy: A Retrospective Evaluation of 15 Cases.

    Güngör O, Dilber C

    Sisli Etfal Hastanesi tip bulteni 2018; (52(1)):47-50 doi:10.14744/SEMB.2017.53496.

    PMID: 32595371
  7. 7

    Isolated Transaminitis as a Sentinel Sign of Duchenne Muscular Dystrophy in an Infant: A Case Report.

    Khalid A, Chaudhry T, Liaqat A, Tufts L

    Cureus 2025; (17(9)):e92233 doi:10.7759/cureus.92233.

    PMID: 41089138
  8. 8

    [A retrospective analysis of 6 children with Duchenne muscular dystrophy].

    Yin YJ, Huang YP, Lu C, et al.

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2017; (19(4)):405-409.

    PMID: 28407826
  9. 9

    A female manifesting carrier of DMD with exon 45 deletion: a case report.

    Jiang QH, Cen YH

    Translational pediatrics 2026; (15(6)):256 doi:10.21037/tp-2026-1-0144.

    PMID: 42433962
  10. 10

    The frequency of Duchenne muscular dystrophy/Becker muscular dystrophy and Pompe disease in children with isolated transaminase elevation: results from the observational VICTORIA study.

    Kansu A, Kuloglu Z, Tümgör G, et al.

    Frontiers in pediatrics 2023; (11()):1272177 doi:10.3389/fped.2023.1272177.

    PMID: 37818166
  11. 11

    Natural History of Serum Enzyme Levels in Duchenne Muscular Dystrophy and Implications for Clinical Practice.

    Rodríguez-Cruz M, Almeida-Becerril T, Atilano-Miguel S, et al.

    American journal of physical medicine & rehabilitation 2020; (99(12)):1121-1128 doi:10.1097/PHM.0000000000001500.

    PMID: 32520799
  12. 12

    Serum Creatine Kinase and Transaminase Levels in Duchenne and Becker Muscular Dystrophies.

    Rohlenová M, Machová K, Baranová J, et al.

    Muscle & nerve 2025; (72(2)):240-249 doi:10.1002/mus.28431.

    PMID: 40350776
  13. 13

    ALT/CK Ratio as an Early Marker of Liver Injury After Gene Therapy in Duchenne Muscular Dystrophy.

    Drakou E, Needum C, Konst K, et al.

    Pediatrics 2026; (157(3)) doi:10.1542/peds.2025-074192.

    PMID: 41672410

This page is for informational purposes only and does not constitute medical advice. Your child’s neuromuscular team should interpret AST, ALT, CK, and other liver tests in context and advise on follow-up.